The hypothalamus, which consists of histologically and functionally distinct subunits, primarily modulates vegetative symptoms in major depressive disorder (MDD). Sex differences in MDD have been well-documented in terms of illness incidence rates and symptom profiles. However, few studies have explored subunit-level and sex-specific anatomic differences in the hypothalamus in MDD compared to healthy controls (HCs). High-resolution 3D T1-weighted images were obtained from 133 treatment-naïve patients with MDD and 130 age-, sex-, education years-, and handedness-matched HCs. MRI data were preprocessed and segmented into ten bilateral hypothalamic subunits with FreeSurfer software. We tested for both common and sex-specific patterns of hypothalamic anatomic differences in MDD. Regardless of sex, patients with MDD showed significantly smaller volumes in the left anterior-inferior subunit (a-iHyp) and larger volumes in the right posterior subunit (posHyp). The volumes of the left a-iHyp were negatively correlated with sleep disturbance scores in the MDD group. A significant sex-by-diagnosis interaction was observed in the right whole hypothalamus, and subsequent post-hoc analyses revealed that males with MDD showed significantly larger volumes, while females with MDD showed significantly smaller volumes relative to their sex-matched HCs. Common differences in MDD were found in the left anterior-inferior and right posterior hypothalamus that are involved in regulating circadian rhythms and reward, while sex-specific differences in MDD were observed in the right whole hypothalamus. These findings enhance our understanding of distinct hypothalamic subunit related to MDD and shed light on the neurobiology underlying sex-related variations in MDD.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s00429-025-02904-w | DOI Listing |
BMC Psychiatry
March 2025
University of South Carolina College of Pharmacy, 715 Sumter Street, Columbia, SC, 29208, USA.
Background: Treatment-resistant depression (TRD) in major depressive disorder (MDD) is defined as the failure of two or more antidepressants. Few studies have characterized the natural history and treatment patterns of these patients. This study aims to identify the natural history of disease and treatment trajectories for patients with TRD.
View Article and Find Full Text PDFBrain Struct Funct
March 2025
Department of Radiology, Huaxi MR Research Center (HMRRC), Institution of Radiology and Medical Imaging, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
The hypothalamus, which consists of histologically and functionally distinct subunits, primarily modulates vegetative symptoms in major depressive disorder (MDD). Sex differences in MDD have been well-documented in terms of illness incidence rates and symptom profiles. However, few studies have explored subunit-level and sex-specific anatomic differences in the hypothalamus in MDD compared to healthy controls (HCs).
View Article and Find Full Text PDFBrain Behav Immun
March 2025
Pathophysiology of Neuropsychiatric Disorders Program, Faillace Department of Psychiatry and Behavioral Sciences, McGovern Medical School, The University of Texas Health Science Center at Houston (UTHealth), Houston, TX, USA; Research and Development, Charlie Norwood VA Medical Center, Augusta, GA, USA. Electronic address:
Recent evidence suggests that the rapid-acting antidepressant ketamine has immune regulatory functions. The complement system is an important component of the innate immune response and plays a key role in synaptic plasticity. An increase in complement component 3 (C3) expression was previously found in the prefrontal cortex of individuals with depression.
View Article and Find Full Text PDFCNS Neurosci Ther
March 2025
Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and the Ministry of Education of China, Guangzhou Medical University, Guangzhou, China.
Aims: Despite the clinical benefits of ketamine in treating major depressive disorder (MDD), some patients exhibit drug resistance, and the intricate mechanisms underlying this await comprehensive explication. We used metabolomics to find biomarkers for ketamine efficacy and uncover its mechanisms of action.
Methods: The study included 40 MDD patients treated with ketamine in the discovery cohort and 24 patients in the validation cohort.
CNS Neurosci Ther
March 2025
Department of Colorectal Diseases, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Background: Previous observational studies have reported a possible association between major depressive disorder (MDD) and abnormal cortical structure. However, it is unclear whether MDD causes reductions in global cortical thickness (CT) and global area (SA).
Objective: We aimed to test the bidirectional causal relationship between MDD and CT and SA using a Mendelian randomization (MR) design and performed exploratory analyses of MDD on CT and SA in different brain regions.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!